[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100425422":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":30,"locations":38,"responsibleParty":56,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":11,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":11,"enrollmentInfo":71,"targetDuration":11,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":40,"whyStopped":11,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Spinal Cord MRI","EXPERIMENTAL",null,[13,14],"Procedure: SC MRI","Other: patient questionnaire",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":11},"PROCEDURE","SC MRI","SC MRI (Averaged Magnetization Inversion Recovery Acquisitions (AMIRA), standard conventional SC MRI sequences, additional sequences for spinal cord MRI (sagittal-2D or 3D short tau inversion recovery, sagittal-2D or 3D phase-sensitive inversion recovery, 3D magnetization prepared 2 rapid acquisition gradient echoes (MPRAGE)). To evaluate the presences of ongoing inflammation (acute or chronic) in the SC of patients, 3D MPRAGE and 3D fluid-attenuated inversion recovery images after intravenous gadolinium (Gd) contrast administration (0.1 mmol per kg body weight) will be acquired.",[9],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"patient questionnaire","12-item multiple sclerosis walking scale (MSWS-12) questionnaire: self-report measure of the impact of MS on the individual's walking ability",[9],[26],{"name":27,"affiliation":28,"role":29},"Katrin Parmar, PD Dr. med.","University Hospital Basel, Department of Neurology","PRINCIPAL_INVESTIGATOR",[31,35],{"name":27,"role":32,"phone":33,"phoneExt":11,"email":34},"CONTACT","+41 61 83 65 214","katrin.parmar@unibas.ch",{"name":36,"role":32,"phone":11,"phoneExt":11,"email":37},"Charidimos Tsagkas, Dr. med.","charidimos.tsagkas@usb.ch",[39],{"facility":28,"status":40,"city":41,"state":11,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Basel","4031","Switzerland","CH",{"type":46,"coordinates":47},"Point",[48,49],7.57327,47.55839,{"lat":49,"lon":48},[52,53,54],{"name":27,"role":32,"phone":11,"phoneExt":11,"email":34},{"name":27,"role":29,"phone":11,"phoneExt":11,"email":11},{"name":36,"role":55,"phone":11,"phoneExt":11,"email":11},"SUB_INVESTIGATOR",{"type":57,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[59],{"name":60,"class":61},"Freie Akademische Gesellschaft Basel","UNKNOWN","100425422","spinal-cord-lesion-detection-in-multiple-sclerosis-using-novel-mri-sequences-100425422",false,"NCT04819737","Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences","Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences: A Pilot Study","Inclusion Criteria:\n\n* Diagnosis of multiple sclerosis according to established international criteria\n* Steroid free period: \\> 4 weeks\n* Participation in the Swiss MS Cohort (SMSC) study\n\nExclusion Criteria:\n\n* . History of severe (other) neurological, internal or psychiatric disease with SC affection\n* MRI-related exclusion criteria (questionnaire):\n\n  1. Paramagnetic and\u002For superparamagnetic foreign objects in the body (especially when located close to the SC)\n  2. Pacemaker\n  3. Claustrophobia\n  4. Pregnancy, lactation\n  5. Known hypersensitivity to gadolinium-based contrast media","ALL","18 Years",{"count":72,"type":73},10,"ESTIMATED","INTERVENTIONAL",[76],"NA","This study is to evaluate the sensitivity and intra-\u002Finter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.",[79],"Multiple Sclerosis (MS)",[81,82,83,84,85],"spinal cord (SC) pathology","demyelinating lesions","Spinal cord MRI","Averaged magnetization inversion recovery acquisitions (AMIRA) sequence","Swiss MS Cohort (SMSC)","2026-03-03",{"date":88,"type":89},"2026-03-05","ACTUAL",{"date":91,"type":89},"2022-07-18",{"date":93,"type":73},"2027-12",{"name":5,"class":6},1]